Promising Arthritis Treatment...360-Degree Surveillance

. . . Promising arthritis treatment - EntreMed (Nasdaq: ENMD) announced preclinical data that showed promising results for 2ME2 in the treatment of rheumatoid arthritis. Oral treatment with 2ME2 resulted in a dose-dependent decrease in the severity of arthritic disease. A decrease in clinical symptoms with 2ME2 administration was accompanied by a marked inhibition of tissue and joint damage that are hallmarks of rheumatoid arthritis. EntreMed is currently evaluating 2ME2 formulations (Panzem® Capsules and Panzem® NCD) in Phase I and II clinical oncology studies, as well as preclinical studies of 2ME2 in inflammatory diseases such as rheumatoid arthritis.

From: www.InvestingIN.com/biotech

. . . 360-degree surveillance - IPIX (NASDAQ:IPIX), a supplier of 360-degree, immersive imaging cameras and technologies is teaming with new video surveillance partners to provide more panoramic threat detection. Recent partnerships include surveillance software manufacturers VistaScape Security Systems and ObjectVideo. IPIX's immersive imaging technology provides security personnel with a more complete, real-time view of a security area, offers a greater level of functionality and reduces the number of necessary cameras, infrastructure and installation costs.

From: www.InvestingIN.com/security